The following trials provide information to treat various types of respiratory and inflammatory diseases, both for ongoing and completed clinical trials. For more information on both of these therapy areas please click here.
- collapse AZD9164 Single Ascending Dose Study in Healthy Male Subjects
- collapse A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®
- collapse Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) Patients
- collapse A 6 months NIS to evaluate the use of rescue medication and quality of life in adult asthmatic subjects treated with Symbicort SMART 1-2 inhalations b.i.d. as maintenance therapy plus additional inhalations as-needed, compared to patients treated with a free combination of an inhaled glucocorticosteroid and an inhaled long acting ß2-agonist plus as needed inhalations of a short acting ß2 agonist.
- collapse A randomised, placebo-controlled, double-blind (double-dummy technique),crossover, multi-centre study, to evaluate onset of effect in patients with Chronic Obstructive Pulmonary Disease (COPD) treated with formoterolTurbuhaler 9 μg, compared with Serevent Diskus 50 μg.
- collapse To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol pMDI a Single Blind Study
- collapse A descriptive study to explore certain characteristics of patients at risk for COPD in a primary care setting.
- collapse A follow-up programme for patients using Symbicort Turbuhaler maintenance and reliever therapy in normal clinical practice.
- collapse Symbicort SMART Satisfaction from Patient Perspective 2009
- collapse A Comparison of SYMBICORT pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.
